Chris Hillier
Plus aucun poste en cours
Profil
Dr. Chris Hillier is Chief Executive Officer at Sistemic.
Dr. Hillier was previously employed as Chief Executive Officer by Biopta Ltd.
and a Professor by Glasgow Caledonian University.
He received his undergraduate degree from Loughborough University and a doctorate degree from the University of Leicester.
Anciens postes connus de Chris Hillier
| Sociétés | Poste | Fin |
|---|---|---|
Sistemic (Scotland) Ltd.
 Sistemic (Scotland) Ltd. Pharmaceuticals: MajorHealth Technology Sistemic (Scotland) Ltd. provides biotechnological solutions. The firm offers analysis of the information content of miRNA profiling and biology, statistical analysis, multi-layered contextual analysis in development of cell therapies and drug repositioning. The company was founded by Chris Hillier in 2008 and is headquartered in Glasgow, the United Kingdom. | Fondateur | - |
| Glasgow Caledonian University | Corporate Officer/Principal | - |
Biopta Ltd.
 Biopta Ltd. Miscellaneous Commercial ServicesCommercial Services Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom. | Fondateur | - |
Formation de Chris Hillier
| Loughborough University | Undergraduate Degree |
| University of Leicester | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Biopta Ltd.
Biopta Ltd. Miscellaneous Commercial ServicesCommercial Services Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom. | Commercial Services |
Sistemic (Scotland) Ltd.
Sistemic (Scotland) Ltd. Pharmaceuticals: MajorHealth Technology Sistemic (Scotland) Ltd. provides biotechnological solutions. The firm offers analysis of the information content of miRNA profiling and biology, statistical analysis, multi-layered contextual analysis in development of cell therapies and drug repositioning. The company was founded by Chris Hillier in 2008 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
